Terminal Cancer
13
4
4
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof
DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
Advanced Planning for Online Accounts and Data
Exploring Indications and Practices of Administering Artificial Hydration to Terminal Cancer Patients in Taiwan
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
Using Wearable Device to Improve Quality of Palliative Care
Information Needs Around Parenteral nUTrition in Cancer
GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.
The Use of Alternative Medicine by Palliative Care Patients
Nasal Fentanyl and Buccal Midazolam for Dying Patients
Diabetes and Palliative Care